| Dr Francis Peter Soans, MD | |
|
7717 E 29th St N Ste 100, Wichita, KS 67226-3444 | |
| (316) 712-4988 | |
| (316) 712-4987 |
| Full Name | Dr Francis Peter Soans |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 35 Years |
| Location | 7717 E 29th St N Ste 100, Wichita, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861495632 | NPI | - | NPPES |
| 201214720A | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 18341 (Mississippi) | Secondary |
| 207WX0009X | Ophthalmology - Glaucoma Specialist | 04-36190 (Kansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vision Surgery Consultants Pa | 2062454622 | 4 |
News Archive
HealthCare.com announces the launch of its new health insurance comparison website that gives consumers more choices to research, shop and buy healthcare plans, which could lead to lowering insurance costs for millions of Americans.
METI, the Sarasota-based manufacturer of medical simulation products and educational software, today announced that it has begun rolling out its groundbreaking, experiential-based Nurse Residency Program at the first of many health care organizations throughout North America.
A novel sensor designed by MIT researchers could dramatically accelerate the process of diagnosing sepsis, a leading cause of death in U.S. hospitals that kills nearly 250,000 patients annually.
Sun Pharmaceutical Industries Ltd., an international specialty pharmaceutical company focused on chronic diseases, through its subsidiary, and Intrexon Corporation, a leader in synthetic biology, today announced the formation of a joint venture to develop controllable gene-based therapies for the treatment of ocular diseases that cause partial or total blindness in millions of people worldwide.
EpiCept Corporation has announced that the European Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has issued, as expected following the trend vote announced last month, a negative opinion regarding the marketing authorization application (MAA) for Ceplene (histamine dihydrochloride) for the remission maintenance and prevention of relapse of patients with Acute Myeloid Leukemia (AML) in first remission.
› Verified 9 days ago
| Entity Name | Wichita Vision Institute Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811932353 PECOS PAC ID: 2961470109 Enrollment ID: O20040924000208 |
News Archive
HealthCare.com announces the launch of its new health insurance comparison website that gives consumers more choices to research, shop and buy healthcare plans, which could lead to lowering insurance costs for millions of Americans.
METI, the Sarasota-based manufacturer of medical simulation products and educational software, today announced that it has begun rolling out its groundbreaking, experiential-based Nurse Residency Program at the first of many health care organizations throughout North America.
A novel sensor designed by MIT researchers could dramatically accelerate the process of diagnosing sepsis, a leading cause of death in U.S. hospitals that kills nearly 250,000 patients annually.
Sun Pharmaceutical Industries Ltd., an international specialty pharmaceutical company focused on chronic diseases, through its subsidiary, and Intrexon Corporation, a leader in synthetic biology, today announced the formation of a joint venture to develop controllable gene-based therapies for the treatment of ocular diseases that cause partial or total blindness in millions of people worldwide.
EpiCept Corporation has announced that the European Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has issued, as expected following the trend vote announced last month, a negative opinion regarding the marketing authorization application (MAA) for Ceplene (histamine dihydrochloride) for the remission maintenance and prevention of relapse of patients with Acute Myeloid Leukemia (AML) in first remission.
› Verified 9 days ago
| Entity Name | Central Plains Eye Mds, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316102726 PECOS PAC ID: 7012085723 Enrollment ID: O20081008000435 |
News Archive
HealthCare.com announces the launch of its new health insurance comparison website that gives consumers more choices to research, shop and buy healthcare plans, which could lead to lowering insurance costs for millions of Americans.
METI, the Sarasota-based manufacturer of medical simulation products and educational software, today announced that it has begun rolling out its groundbreaking, experiential-based Nurse Residency Program at the first of many health care organizations throughout North America.
A novel sensor designed by MIT researchers could dramatically accelerate the process of diagnosing sepsis, a leading cause of death in U.S. hospitals that kills nearly 250,000 patients annually.
Sun Pharmaceutical Industries Ltd., an international specialty pharmaceutical company focused on chronic diseases, through its subsidiary, and Intrexon Corporation, a leader in synthetic biology, today announced the formation of a joint venture to develop controllable gene-based therapies for the treatment of ocular diseases that cause partial or total blindness in millions of people worldwide.
EpiCept Corporation has announced that the European Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has issued, as expected following the trend vote announced last month, a negative opinion regarding the marketing authorization application (MAA) for Ceplene (histamine dihydrochloride) for the remission maintenance and prevention of relapse of patients with Acute Myeloid Leukemia (AML) in first remission.
› Verified 9 days ago
| Entity Name | Vision Surgery Consultants Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922104470 PECOS PAC ID: 2062454622 Enrollment ID: O20100526000491 |
News Archive
HealthCare.com announces the launch of its new health insurance comparison website that gives consumers more choices to research, shop and buy healthcare plans, which could lead to lowering insurance costs for millions of Americans.
METI, the Sarasota-based manufacturer of medical simulation products and educational software, today announced that it has begun rolling out its groundbreaking, experiential-based Nurse Residency Program at the first of many health care organizations throughout North America.
A novel sensor designed by MIT researchers could dramatically accelerate the process of diagnosing sepsis, a leading cause of death in U.S. hospitals that kills nearly 250,000 patients annually.
Sun Pharmaceutical Industries Ltd., an international specialty pharmaceutical company focused on chronic diseases, through its subsidiary, and Intrexon Corporation, a leader in synthetic biology, today announced the formation of a joint venture to develop controllable gene-based therapies for the treatment of ocular diseases that cause partial or total blindness in millions of people worldwide.
EpiCept Corporation has announced that the European Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has issued, as expected following the trend vote announced last month, a negative opinion regarding the marketing authorization application (MAA) for Ceplene (histamine dihydrochloride) for the remission maintenance and prevention of relapse of patients with Acute Myeloid Leukemia (AML) in first remission.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Francis Peter Soans, MD 7717 E 29th St N Ste 100, Wichita, KS 67226-3444 Ph: (316) 712-4970 | Dr Francis Peter Soans, MD 7717 E 29th St N Ste 100, Wichita, KS 67226-3444 Ph: (316) 712-4988 |
News Archive
HealthCare.com announces the launch of its new health insurance comparison website that gives consumers more choices to research, shop and buy healthcare plans, which could lead to lowering insurance costs for millions of Americans.
METI, the Sarasota-based manufacturer of medical simulation products and educational software, today announced that it has begun rolling out its groundbreaking, experiential-based Nurse Residency Program at the first of many health care organizations throughout North America.
A novel sensor designed by MIT researchers could dramatically accelerate the process of diagnosing sepsis, a leading cause of death in U.S. hospitals that kills nearly 250,000 patients annually.
Sun Pharmaceutical Industries Ltd., an international specialty pharmaceutical company focused on chronic diseases, through its subsidiary, and Intrexon Corporation, a leader in synthetic biology, today announced the formation of a joint venture to develop controllable gene-based therapies for the treatment of ocular diseases that cause partial or total blindness in millions of people worldwide.
EpiCept Corporation has announced that the European Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has issued, as expected following the trend vote announced last month, a negative opinion regarding the marketing authorization application (MAA) for Ceplene (histamine dihydrochloride) for the remission maintenance and prevention of relapse of patients with Acute Myeloid Leukemia (AML) in first remission.
› Verified 9 days ago
David M Kahn, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 818 N Carriage Pkwy, Wichita, KS 67208 Phone: 316-651-2300 Fax: 316-651-2358 | |
Dasa V Gangadhar, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 655 N Woodlawn, Wichita, KS 67206 Phone: 316-684-5158 Fax: 316-681-1005 | |
C Eric Shrader, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 655 N Woodlawn, Wichita, KS 67208 Phone: 316-684-5158 Fax: 316-858-3830 | |
Dr. David A Kingrey, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1100 N Topeka St, Wichita, KS 67214 Phone: 316-263-6273 Fax: 316-263-5568 | |
Dr. Anita Campbell, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1277 N Maize Rd, Wichita, KS 67212 Phone: 316-722-8883 Fax: 316-609-4740 | |
Michael S Bolt, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 834 N Socora, Ste 2, Wichita, KS 67212 Phone: 316-722-8883 Fax: 316-721-4864 | |
Terria L Winn, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 834 N Socora St, Wichita, KS 67212 Phone: 316-722-8883 Fax: 316-721-4864 |